Insider Transactions in Q2 2021 at Repligen Corp (RGEN)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2021
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
6,802
-24.16%
|
$1,285,578
$189.19 P/Share
|
|
Jun 10
2021
|
Ralf Kuriyel Senior VP, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
3,602
+6.1%
|
$259,344
$72.81 P/Share
|
|
May 19
2021
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
22,267
-1.37%
|
$3,807,657
$171.83 P/Share
|
|
May 14
2021
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
470
-1.45%
|
$80,840
$172.6 P/Share
|
|
May 14
2021
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
710
-2.81%
|
$122,120
$172.29 P/Share
|
|
May 14
2021
|
Christine Gebski |
SELL
Open market or private sale
|
Direct |
445
-1.2%
|
$76,540
$172.25 P/Share
|
|
May 13
2021
|
Karen A Dawes |
BUY
Grant, award, or other acquisition
|
Direct |
604
+0.52%
|
-
|
|
May 13
2021
|
Rohin Mhatre |
BUY
Grant, award, or other acquisition
|
Direct |
457
+50.0%
|
-
|
|
May 13
2021
|
Thomas F Ryan Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+20.7%
|
-
|
|
May 13
2021
|
Nicolas Barthelemy |
BUY
Grant, award, or other acquisition
|
Direct |
457
+19.33%
|
-
|
|
May 13
2021
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
457
+6.7%
|
-
|
|
May 13
2021
|
Manner Carrie Eglinton |
BUY
Grant, award, or other acquisition
|
Direct |
457
+50.0%
|
-
|
|
May 11
2021
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
285
-0.25%
|
$50,160
$176.85 P/Share
|
|
May 11
2021
|
Karen A Dawes |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+11.47%
|
$45,000
$3.22 P/Share
|
|
Apr 06
2021
|
James Bylund Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
360
-5.39%
|
$73,440
$204.25 P/Share
|